Production (Stage)
NeuPath Health Inc.
NPTH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 40.48% | -235.92% | 177.14% | -3.39% | -196.48% |
| Total Depreciation and Amortization | -0.36% | 4.33% | -6.22% | -20.57% | 16.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.34% | 1.38% | 9.56% | 37.80% | 133.45% |
| Change in Net Operating Assets | -139.05% | 438.82% | 120.85% | -279.21% | 21,957.14% |
| Cash from Operations | -54.35% | -26.67% | 1,259.72% | -88.43% | 69.01% |
| Capital Expenditure | -29.78% | 52.86% | -800.29% | 60.43% | -49.75% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -22.01% | 52.86% | -90.77% | -86.73% | -106.35% |
| Total Debt Issued | -200.00% | -- | -- | -- | -- |
| Total Debt Repaid | 25.52% | -0.63% | 12.52% | 5.89% | 68.03% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 0.00% | -52.00% | -20.63% | 28.57% |
| Cash from Financing | 13.45% | 4.58% | 9.87% | 3.20% | 71.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -182.64% | -22.82% | 152.48% | -572.18% | -76.24% |